U.S. ruling gives Sackler family, owners of Purdue Pharma, immunity from opioid lawsuits - Action News
Home WebMail Friday, November 22, 2024, 06:44 AM | Calgary | -13.3°C | Regions Advertise Login | Our platform is in maintenance mode. Some URLs may not be available. |
World

U.S. ruling gives Sackler family, owners of Purdue Pharma, immunity from opioid lawsuits

The Sackler family, the wealthy owners of Purdue Pharma, will be shielded from future lawsuits related to the opioid epidemic under a plan approved by a U.S. federal appeals court.

Family would have to contribute up to $6B US to fund for addiction prevention and treatment

Bottles of OxyContin pills.
Bottles of prescription painkiller OxyContin pills, made by Purdue Pharma, sit on a counter at a pharmacy in Provo, Utah, in this April 2017 photo. (George Frey/Reuters)

The Sackler family, the wealthy owners of Purdue Pharma, will be shielded from future lawsuits related to the opioid epidemic under a plan approved by a U.S. federal appeals court.

The plan would also see the family contribute up to $6 billion US to a fund to prevent and treat addiction.

Approved on Tuesday by the 2nd U.S. Circuit Court of Appeals in New York, the plan clears the way for Purdue Pharma, the maker of the painkiller OxyContin, to settle thousands of legal claims tied to the opioid epidemic.

Members of the Sackler family would give up ownership of Stamford, Conn.,-based Purdue, which would become a new company known as Knoa, with its profits being sent to the addiction fund.

Money for victims

Family members would also contribute $5.5 billion US to $6 billion US in cash over time, or around half of what the court found to be their collective fortune, much of it held offshore. A chunk of that money at least $750 million US is to go to individual victims of the opioid crisis and their survivors. Payments are expected to range from about $3,500 US to $48,000 US.

Tuesday's decision also protects members of the Sackler family from lawsuits over the toll of opioids, even though they did not file for bankruptcy.

The court's ruling reversed a 2021 ruling that found bankruptcy court judges did not have the authority to approve a settlement that would offer bankruptcy protections for those who have not filed for bankruptcy.

Those protections are at the heart of the proposed deal that would end claims filed by thousands of state, local and Native American tribal governments and other entities. Sackler family members have been clear that without the protections, they won't hold up their part of the deal.

'Waiting for this day'

"It's a great day for victims, some of who desperately need the money and have been waiting for this day for a long time," said Ed Neiger, a lawyer representing individual victims.

A woman holds two photographs of her sons.
Cheryl Juaire poses on March 10, 2022, with photos of her sons, Sean Merrill, left, and Corey Merrill, who died from overdoses. (Seth Wenig/The Associated Press)

Cheryl Juaire, a Massachusetts woman who lost two sons to overdoses, said she does not know what size payment to expect. "My children are gone and there's nothing I can do to bring them back," she said, but she said the funds would help her sons' children. "They'll have braces, they'll have glasses, they'll have things they need that they wouldn't have otherwise."

Sackler family members and Purdue also praised the decision.

"The Sackler families believe the long-awaited implementation of this resolution is critical to providing substantial resources for people and communities in need," family members who own Purdue said in a statement Tuesday. "We are pleased with the court's decision to allow the agreement to move forward and look forward to it taking effect as soon as possible."

One non-financial term of their part of the deal is already fulfilled: listening silently, via Zoom, to the stories of some of the people harmed by their company's drug.

Purdue issued its own statement, calling the ruling "a victory for Purdue's creditors, including the states, local governments, and victims who overwhelmingly support the Plan of Reorganization." The company said it would focus on delivering "billions of dollars of value for victim compensation, opioid crisis abatementand overdose rescue medicines."

Several states had withheld support for the plan, but after a new round of negotiations last year, all of them came on board. That left just one high-profile objector: the Office of the U.S. Bankruptcy Trustee, an arm of the Justice Department.

A lawyer from that office told the 2nd Circuit in April 2022 that it's a "fundamental inconsistency" that people who do not seek bankruptcy protection and have to give up most of their assets could be exempted from some lawsuits.

The U.S. Justice Department did not immediately say whether it would appeal Tuesday's ruling to the U.S. Supreme Court, ask the Circuit Court to review its decision or accept the ruling as is. A spokesperson declined comment on Tuesday.

Even without an appeal, it could be months before the bankruptcy plan takes effect.

Some activists have also opposed the settlement and called for Sackler family members to be prosecuted for crimes. While the settlement wouldn't block that, there's no indication that charges are forthcoming.

While Sackler family members still technically own Purdue, they stopped receiving money from the company years ago.